VPS36 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.943800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.094200E-01
Normal-vs-Stage2
2.943000E-01
Normal-vs-Stage3
1.157590E-01
Normal-vs-Stage4
5.598000E-01
Stage1-vs-Stage2
2.123000E-01
Stage1-vs-Stage3
7.606400E-02
Stage1-vs-Stage4
6.126800E-01
Stage2-vs-Stage3
1.484830E-01
Stage2-vs-Stage4
6.662400E-01
Stage3-vs-Stage4
6.807900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.749200E-01
Normal-vs-AfricanAmerican
7.414400E-01
Normal-vs-Asian
2.510200E-01
Caucasian-vs-AfricanAmerican
3.745800E-01
Caucasian-vs-Asian
6.495200E-01
AfricanAmerican-vs-Asian
3.266400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.949000E-01
Normal-vs-Female
3.169600E-01
Male-vs-Female
8.641000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.878400E-01
Normal-vs-Age(41-60Yrs)
3.909600E-01
Normal-vs-Age(61-80Yrs)
2.579000E-01
Normal-vs-Age(81-100Yrs)
4.862000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.456000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.943800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.173600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.538000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.098200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.271000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.974050E-01
Normal-vs-Daily Drinker
2.305400E-01
Normal-vs-Weekly Drinker
1.875820E-01
Normal-vs-Occasional Drinker
3.141000E-01
Normal-vs-Social Drinker
3.885400E-01
Non Drinker-vs-Daily Drinker
7.824400E-01
Non Drinker-vs-Weekly Drinker
4.877200E-01
Non Drinker-vs-Occasional Drinker
4.435400E-01
Non Drinker-vs-Social Drinker
4.064400E-01
Daily Drinker-vs-Weekly Drinker
6.992200E-01
Daily Drinker-vs-Occasional Drinker
3.662400E-01
Daily Drinker-vs-Social Drinker
3.492600E-01
Weekly Drinker-vs-Occasional Drinker
2.127800E-01
Weekly Drinker-vs-Social Drinker
2.151400E-01
Occasional Drinker-vs-Social Drinker
8.989800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.939800E-02
Normal-vs-Grade 2
3.984500E-04
Normal-vs-Grade 3
3.019000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.364000E-01
Grade 1-vs-Grade 3
8.599200E-01
Grade 1-vs-Grade 4
2.939800E-02
Grade 2-vs-Grade 3
8.086800E-01
Grade 2-vs-Grade 4
3.984500E-04
Grade 3-vs-Grade 4
3.019000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.272830E-01
Normal-vs-NonDiabetic
2.710600E-01
Diabetic-vs-NonDiabetic
1.471180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.372000E-01
Normal-vs-NoPancreatitis
2.361800E-01
Pancreatitis-vs-NoPancreatitis
9.061000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.755000E-01
Normal-vs-N1
2.848400E-01
N0-vs-N1
7.148400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.883600E-01
Normal-vs-TP53-NonMutant
5.591400E-01
TP53-Mutant-vs-TP53-NonMutant
9.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
